Quote:Gleevec worked so well and so quickly that the trial testing the drug against the older chemo regimen was stopped so everyone could get the pill. Food and Drug Administration approval was swift and now the Leukemia & Lymphoma Society estimates 36,000 to 100,000 Americans are CML survivors.
Wow, here's a great quote from the article, about stopping
Top 10 Most Recent News Articles
Bandwidth Welcomes Chip Schroeder: Key Board Makeover
Turning the Page at Bandwidth Bandwidth Inc. (NASDAQ:BAND) just shook up its executive roster by bringing in a heavy hitter. Chip Schroeder's landing on the board is a bold move from a strategic player in the cloud communications space. This guy's not your average board member; he's a veteran navigator through stormy market waters, and at Bandwidth, it seems he'll be...
Continue Reading
Bitcoin Mortgages: APX Ushers in New Canadian Era
Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...
Continue Reading
Wood Partners Expands Charlotte Footprint with New Project
Charlotte's Expansion Beckons New Development at Village Park Charlotte's skyline is about to get a new neighbor in a growing district, as Wood Partners is set to break ground yet again, unveiling its ambitious plans for Village Park. This is not just a hodgepodge construction talk—it’s the company’s latest effort to plant its flag deep in the heart of the Queen...
Continue Reading
Proton Therapy: A Game-changer in Breast Cancer Treatment
Understanding the Radiation Conundrum When it comes to breast cancer, there's no sugarcoating it—the diagnosis alone can shake the foundation of anyone's life. But once the dust settles, another layer of decisions begins. One of the trickiest questions patients face is, "What radiation options are out there?" That's where proton therapy comes in, and it's high time we...
Continue Reading
Envision Expands SAFc to New Global Heights
Globetrotting Green: Envision's SAFc Goes International If there's one thing Envision is out to prove, it's that the sky's not the limit but rather a stepping stone in their quest for sustainability. This latest venture isn't just another green initiative; it's a bold expansion into the international stage with their Sustainable Aviation Fuel certificate (SAFc). Conceived...
Continue Reading
ATI's Financial Runway: $1.42B Sales and Rising
ATI's Stellar Third Quarter: Beyond Expectations Today, ATI Inc. dropped a third-quarter performance that's got Wall Street abuzz—in a good way. The numbers speak volumes: ATI's sales soared by 26% to reach a cool $1.42 billion, smashing last year's results to bits. If you were banking on NYSE:ATI to keep your portfolio afloat, well, let's just say you're sitting...
Continue Reading
Virax Biolabs Expands China Reach With Key Partnerships
Virax Biolabs' Strategic Play in China Does Virax Biolabs have a trick up its sleeve, or is it just rolling the dice in the vast Chinese market? With three new distributor agreements, it sure seems like it's trying to tip the scales in its favor. The London-based company announced new distribution agreements for its ImmuneSelect research-use immune profiling products....
Continue Reading
Fed Holds Steady, But CD Rates Climb: Savers' Edge
The Fed Sits Tight, But CD Rates Surge Isn't it a kicker when the Fed holds rates steady, yet the CD market is buzzing like a crowded trading floor on a bull run? We've seen the Federal Reserve hold its ground without budging interest rates, keeping everyone guessing while inflation's still a shadow in the corner. But the star of the show here isn't the Fed's poker...
Continue Reading
ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion
ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...
Continue Reading
2026 Global Ocean Forum Unveils Key Marine Strategies
Riding the Waves in Qingdao It ain't every day that a talk-fest dedicated to oceans gets my attention, but when the Global Ocean Development Forum plants its flag in Qingdao, even I sit up. We're talking about some real fireworks in the marine economy sector with this gig's '1+1+4+8' framework. Now, before you scratch your head on the bingo numbers—it's the opening...
Continue ReadingTop 5 Most Recently Viewed Articles
EDP Renewables Honors Ten Milestones in Sustainable Energy Projects
EDP Renewables Celebrates Key Achievements in Renewable Energy Across North America, these ten projects have successfully generated renewable energy, providing power to more than 476,400 homes each year. Anniversary Celebrations EDP Renewables North America LLC (EDPR NA), a prominent player in renewable energy development, proudly commemorates the 5- and 10-year...
Continue Reading
Verizon's Key Participation in Upcoming Deutsche Bank Conference
Verizon's Upcoming Conference Appearance Verizon Communications Inc. (NASDAQ: VZ) is gearing up for a significant event as Frank Boulben, the senior vice president and chief revenue officer for the Consumer Group, prepares to speak at the Deutsche Bank Media, Internet & Telecom Conference. This important appearance is scheduled for March 11 at 8:00 a.m. ET and will be...
Continue Reading
Revolutionizing AI Podcasts: The Soul App's New Voice Model
The New Era of AI Podcasts with SoulX-Podcast Soul AI Lab, the innovative tech team behind the Soul App, is bringing a transformative advancement to the world of podcasting with the release of its groundbreaking open-source voice podcast generation model, SoulX-Podcast. This voice generation model has been tailored for multi-speaker, multi-turn dialogue, making it...
Continue Reading
Vulcan Materials Earnings Forecast: What to Expect and More
Vulcan Materials Anticipates Earnings Announcement Vulcan Materials (NYSE: VMC) is gearing up for its upcoming quarterly earnings report. Investors are closely monitoring this event, expecting to gain insights into the company's performance and future outlook. What Analysts Are Predicting Analysts are forecasting that Vulcan Materials will announce an earnings per share...
Continue Reading
Sagimet Biosciences Set to Showcase Fibrosis Findings at AASLD
Sagimet Biosciences to Present Key Findings at AASLD 2025 Sagimet Biosciences Inc. (Nasdaq: SGMT), a pioneering biopharmaceutical company focused on innovative therapies targeting metabolic disorders, has exciting news for the medical community. They are set to present new findings at the upcoming American Association for the Study of Liver Disease (AASLD) - The Liver...
Continue Reading